Clinical trial NCT03717974: Medico-economic Impact Evaluation in Telemedecine Follow-up in Complement of a Mobile Team in Patients With Neurological Disabilities (HANDI@CCESS)
Official title: Randomized Controlled Pilot Study for Medico-economic Impact Evaluation in Telemedecine Follow-up in Complement of a Mobile Team in Patients With Neurological Disabilities (HANDI@CCESS)
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Severe Neurological Disabilities
Keywords: telemedecine
medico-economic
neurological disability
Lead sponsor: Pôle Saint Hélier
Sponsor class: OTHER
Collaborators: name: Clinique Mutualiste la Sagesse
First posted: 2018-10-24
Enrollment: 80
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Intervention model description: Monocentric, randomized controlled pilot study
Primary purpose: OTHER

Brief summary: Access to care for people with traumatic or degenerative neurological disabilities is a current public health concern. New technological tools such as telemedicine can bring expertise to the place of life of people while promoting the city-hospital link.


Eligibility criteria: Inclusion Criteria:

* Patients over 18
* Volunteer to participate in the study and whose primary caregiver is voluntary
* Presenting a severe neurological handicap following a neurological lesion of traumatic, vascular or degenerative origin,
* Requiring an expert opinion in MPR (rehabilitation, technical and human compensatory means, specific treatments ...) and / or in algology
* Whose access to care is reduced (difficulties of movement, distance from expert centers, situation of fragility ...) and which necessitate the displacement of professionals at home,
* Which require a coordination of care associating the professionals of the sanitary and medico-social sectors
* Living in health territory 5 in Brittany
* Mastering the French language spoken and / or written.

Exclusion Criteria:

* Misunderstanding making it impossible for informed consent with the refusal of the guardian or court safeguard
* Unable to use a digital tablet or lack of a resource person who can assist the patient in the use of the tablet
* Patients who do not have access to an internet connection (white area)
* Life threatening is committed in the short term (\< 3 months)

Primary outcomes:
measure: Medical-economic analysis by the calculation of the cost-effectiveness of this organization of care
timeFrame: 6 months
Secondary outcomes:
measure: UTAUT (Unified theory of acceptance of technology) questionnaire
timeFrame: 6 months
measure: Hospital Anxiety and Depression scale (HAD)
timeFrame: 6 months
measure: Pain evaluation
timeFrame: 6 months
measure: DN4 scale
timeFrame: 6 months
measure: Doloplus scale
timeFrame: 6 months
measure: Zarit's score
timeFrame: 6 months
measure: Goal Attainment Scale
timeFrame: 6 months
measure: EVA Satisfaction
timeFrame: 6 months
Other outcomes:
Locations:
city: Rennes
country: France
facility: Pôle Saint-Hélier
Study officials:
affiliation: Pole Saint-Hélier
name: Philippe Gallien, Doctor
role: PRINCIPAL_INVESTIGATOR
References: